Date published: 2025-9-10

00800 4573 8000

SCBT Portrait Logo
Seach Input

Lefty Inhibidores

Lefty inhibitors belong to a distinct class of chemical compounds known for their pivotal role in regulating embryonic development and cell differentiation. These inhibitors are closely associated with the transforming growth factor-beta (TGF-β) superfamily of signaling molecules. To understand Lefty inhibitors, it's essential to appreciate their role within the intricate process of embryogenesis. During early development, Lefty inhibitors play a fundamental role in establishing the body plan of an organism. They are known for their function in maintaining symmetry and axis formation, a critical step in the early stages of embryonic development. Lefty inhibitors act as antagonists to certain signaling pathways within the TGF-β superfamily, exerting their influence by interfering with the signaling molecules involved. Specifically, they counteract the activity of Nodal, an important TGF-β member, which plays a key role in specifying the left-right axis in vertebrates. By doing so, Lefty inhibitors help ensure that the developing embryo forms with appropriate bilateral symmetry, preventing developmental abnormalities and ensuring the proper organization of vital organs.

Lefty inhibitors can be broadly classified into two isoforms: Lefty-1 and Lefty-2. Both isoforms exhibit similar mechanisms of action, working as negative regulators by binding to Nodal and inhibiting its signaling. This function is crucial for maintaining the balance of the Nodal pathway, preventing excessive or inappropriate signaling that could lead to developmental defects. Lefty inhibitors are a prime example of the delicate checks and balances that govern embryonic development. Their presence ensures the precise orchestration of signaling pathways, guaranteeing that an organism's body plan and symmetry are established correctly during its early stages of development. Understanding the mechanisms of Lefty inhibitors is not only essential for developmental biology but also holds potential implications for various fields of science and medicine, shedding light on the intricacies of cell signaling and differentiation.

VER TAMBIÉN ....

Items 1 to 10 of 15 total

Mostrar:

Nombre del productoNÚMERO DE CAS #Número de catálogoCantidadPrecioMENCIONESClasificación

BIBF1120

656247-17-5sc-364433
sc-364433A
5 mg
10 mg
$180.00
$315.00
2
(0)

El nintedanib es un inhibidor de la tirosina cinasa que actúa sobre múltiples receptores, como el VEGFR, el FGFR y el PDGFR, inhibiendo las vías de la angiogénesis y la fibrosis.

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$44.00
$109.00
61
(1)

El imatinib inhibe la tirosina quinasa BCR-ABL, impidiendo la señalización aberrante en la leucemia mieloide crónica (LMC) y los tumores del estroma gastrointestinal (GIST).

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Este compuesto inhibe ampliamente la transcripción y podría reducir la expresión de numerosos genes, entre ellos LEFTY.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

El sorafenib se dirige a las quinasas RAF y VEGFR, interrumpiendo las vías MAPK y VEGF, que intervienen en el crecimiento y la propagación de las células.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$74.00
$119.00
33
(1)

El erlotinib inhibe la tirosina quinasa EGFR, bloqueando las vías de señalización que promueven el crecimiento y la división celular.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Un inhibidor de la traducción de proteínas que podría reducir la síntesis de proteínas LEFTY.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

El sunitinib inhibe el VEGFR, el PDGFR y otras quinasas, interfiriendo en la angiogénesis y la proliferación de células tumorales, y se utiliza principalmente en el carcinoma de células renales.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

El gefitinib es un inhibidor de la tirosina quinasa EGFR, que detiene el crecimiento y la división de las células al interrumpir las vías de señalización impulsadas por el EGFR.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

El dasatinib se dirige contra BCR-ABL y otras quinasas, suprimiendo la proliferación de las células leucémicas, y se utiliza principalmente para la leucemia mieloide crónica (LMC).

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$35.00
$115.00
$515.00
26
(1)

Dada la interacción entre las señales Wnt y TGF-β, inhibidores como XAV-939 o ICG-001 podrían modular indirectamente la expresión o la actividad de LEFTY.